Dagnew Fisseha Nigussie, Wondm Samuel Agegnew, Mengistu Melak Erara, Dagnew Samuel Berihun, Moges Tilaye Arega, Mekonnen Gashaw Binega
Department of Clinical Pharmacy, Pharmacy Education and Clinical Services Directorate, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia.
Department of Clinical Pharmacy, College of Health Sciences, Debre Tabor University, P.O. Box 272, Debre Tabor, Ethiopia.
Sci Rep. 2025 Jul 25;15(1):27132. doi: 10.1038/s41598-025-86293-4.
Thyroid disorder patients are likely to have a prescription for various categories of drugs including those with a narrow therapeutic index and others, which affects thyroid function. However, information regarding drug therapy problems in thyroid patients has not been studied here yet. Thus this study aimed to assess drug therapy problems and associated factors among thyroid disorder patients, who had follow-ups at Northwest Hospitals of Ethiopia. A multicenter hospital-based cross-sectional study design was employed through patient interviews and chart review at public hospitals in Northwest Ethiopia. A simple random sampling technique was used to recruit patients for interviews. The identified drug-related problem was recorded and classified using Cipolle et al. 2012, adverse drug reactions were assessed by using the Naranjo algorithm of adverse drug reaction probability scale, and Up-to-date was used for the drug-drug interaction checker. The collected data was cleared, entered into epidata, checked for correctness, and exported to STATA version 17 for analysis. The results were summarized using descriptive statistics including frequency, mean, median, and standard deviation. Logistic regression analysis was conducted to identify the independent predictors of drug therapy problems. A P-value < 0.05 is considered statistically significant. Among 351 study participants most of them 300 (85.47%) were females. The study participants' mean (± SD) age was 45.1± (0.74) years. At least one drug-related problem was recorded from 60.11%, (95% CI: 54.9-65.13) of study participants with a mean of 1.54 ± 0.046 drug-related problems per patient. The most common drug-related problems were non-adherence (34.47%) followed by adverse drug reactions (17.2%) and ineffective drug therapy (8.2%). Factors independently associated with drug-related problems were age [AOR = 2.85, 95%CI: (1.05-7.69), P-value = 0.039], poly-pharmacy [AOR = 2.57, 95%CI: (1.01-6.29), P-value = 0.046], comorbidity [AOR = 2.09, 95%CI: (1.07-4.05), P-value = 0.030], and purchasing medication from private pharmacy [AOR = 2.62, 95%CI: (1.06-6.49), P-value = 0.038]. The prevalence of drug-related problems among adult thyroid disease patients who had follow up at ambulatory clinics was very high. Age, poly-pharmacy, comorbidity, and purchasing medication in private pharmacies were independent predictors of drug-related problems. The most commonly involved medication class in experiencing drug-related problems was thionamides.
甲状腺疾病患者可能会开具各类药物的处方,包括治疗指数窄的药物及其他影响甲状腺功能的药物。然而,关于甲状腺疾病患者药物治疗问题的信息在此尚未得到研究。因此,本研究旨在评估在埃塞俄比亚西北部医院接受随访的甲状腺疾病患者中的药物治疗问题及相关因素。通过在埃塞俄比亚西北部公立医院对患者进行访谈和病历审查,采用了基于多中心医院的横断面研究设计。使用简单随机抽样技术招募患者进行访谈。使用Cipolle等人2012年的方法记录并分类已识别的药物相关问题,使用药物不良反应概率量表的Naranjo算法评估药物不良反应,并使用Up-to-date进行药物相互作用检查。收集的数据进行清理、录入EpiData、检查正确性,然后导出到STATA 17版本进行分析。结果使用包括频率、均值、中位数和标准差在内的描述性统计进行总结。进行逻辑回归分析以确定药物治疗问题的独立预测因素。P值<0.05被认为具有统计学意义。在351名研究参与者中,大多数300名(85.47%)为女性。研究参与者的平均(±标准差)年龄为45.1±(0.74)岁。60.11%(95%CI:54.9 - 65.13)的研究参与者记录到至少一个药物相关问题,每位患者平均有1.54±0.046个药物相关问题。最常见的药物相关问题是不依从(34.47%),其次是药物不良反应(17.2%)和药物治疗无效(8.2%)。与药物相关问题独立相关的因素包括年龄[AOR = 2.85,95%CI:(1.05 - 7.69),P值 = 0.039]、联合用药[AOR = 2.57,95%CI:(1.01 - 6.29),P值 = 0.046]、合并症[AOR = 2.09,95%CI:(1.07 - 4.05),P值 = 0.030]以及从私立药房购买药物[AOR = 2.62,95%CI:(1.06 - 6.49),P值 = 0.038]。在门诊接受随访的成年甲状腺疾病患者中,药物相关问题的患病率非常高。年龄、联合用药、合并症以及在私立药房购买药物是药物相关问题的独立预测因素。经历药物相关问题时最常涉及的药物类别是硫代酰胺类。